• Final NHS nod for Roche’s RoActemra pharmatimes
    July 16, 2018
    Roche/Chugai’s RoActemra should be routinely offered throughout the NHS to adults with giant cell arteritis (GCA) within the next three months, following a final green light from cost regulators.
PharmaSources Customer Service